Randomized, Prospective Comparison of the Outcome of Toric Implantable Contact Lens (TICL) and Q-LASIK for the Correction of Myopia With Astigmatism

NCT01088568 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-03-17

No results posted yet for this study

Summary

The objective is to conduct a contralateral prospective clinical study to compare the safety, efficacy, and quality of vision of the STAAR Surgical Co. Toric Implantable Contact Lens TICL) versus Custom Laser Vision Correction (Q-LASIK) in human eyes for the correction of myopia with astigmatism.

Conditions

  • Myopia
  • Astigmatism

Interventions

PROCEDURE

the implantation of toric implantable collamer lens

perform the implantation of toric implantable collamer lens for both eyes

PROCEDURE

customized laser-assisted in situ keratomileusis

perform Q-factor customized laser-assisted in situ keratomileusis for both eyes

Sponsors & Collaborators

  • Staar Surgical Company

    collaborator INDUSTRY
  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Qin Mei Wang · Eye hospital of Wenzhou Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-12-31
Completion
2010-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088568 on ClinicalTrials.gov